BioIntelliSense

About:

BioIntelliSense, a continuous health monitoring and clinical intelligence company with medical-grade wearable devices and Data-as-a-Service.

Website: https://www.biointellisense.com/

Twitter/X: biointellisense/status/1233422838939475970

Top Investors: Fresenius Medical Care, U.S. Department of Defense, Fresenius Medical Care North America, 7wire Ventures, Chimera Investment

Description:

BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM) and Health Screening. BioIntelliSense's medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The FDA-cleared BioSticke and BioButton devices make remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians will now have access to high-resolution patient trending and reporting to enable medical-grade care from the hospital to the home, and all points in-between.